Necrostatin-1 ameliorates symptoms in R6/2 transgenic mouse model of Huntington's disease

Cell Death and Disease

Volumn 2, Issue 1, 2011, Pages

  Zhu, S ^a   Zhang, Y ^a   Bai, G ^b   Li, H ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; MITOGEN ACTIVATED PROTEIN KINASE; NECROSTATIN 1; PROTEIN; RIP1; UNCLASSIFIED DRUG; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; IMIDAZOLE DERIVATIVE; INDOLE DERIVATIVE; NECROSTATIN-1; RALBP1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CONTROLLED STUDY; EXCITOTOXICITY; HUNTINGTON CHOREA; LETTER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRIATE CORTEX; TRANSGENIC MOUSE; ANIMAL; CELL LINE; DISEASE MODEL; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; PATHOPHYSIOLOGY;

MUS MUSCULUS;

ANIMALS; APOPTOSIS; CELL LINE; DISEASE MODELS, ANIMAL; GTPASE-ACTIVATING PROTEINS; HUMANS; HUNTINGTON DISEASE; IMIDAZOLES; INDOLES; MICE; MICE, TRANSGENIC;

EID: 79954525274     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2010.94     Document Type: Letter

References (20)

1. The Huntington's Disease Collaborative Research Group. Cell 1993; 72: 971-983.
2. Zuccato C, Valenza M, Cattaneo E. Physiol Rev 2010; 90: 905-981.
3. Vonsattel JP et al. J Neuropathol Exp Neurol 1985; 44: 559-577.
4. Vandenabeele P et al. Nat Rev Mol Cell Biol 2010; 11: 700-714.
5. Degterev A et al. Nat Chem Biol 2008; 4: 313-321.
6. Ehrlich ME et al. Exp Neurol 2001; 167: 215-226.
7. Varma H et al. Proc Natl Acad Sci USA 2007; 104: 14525-14530.
8. Wang X et al. J Neurosci 2008; 28: 9473-9485.
9. Mangiarini L et al. Cell 1996; 87: 493-506.
10. Jagtap PG et al. J Med Chem 2007; 50: 1886-1895.
11. Yu L et al. Science 2004; 304: 1500-1502.
12. Hartmann A et al. J Neurosci 2001; 21: 2247-2255.
13. Gokce O et al. PLoS One 2009; 4: e5292.
14. Adams JP, Sweatt JD. Annu Rev Pharmacol Toxicol 2002; 42: 135-163.
15. Apostol BL et al. Hum Mol Genet 2006; 15: 273-285.
16. Lievens JC et al. Mol Cell Neurosci 2002; 20: 638-648.
17. Friedlander RM. N Engl J Med 2003; 348: 1365-1375.
18. Graham RK et al. J Neurosci 2009; 29: 2193-2204.
19. Han W et al. Apoptosis 2009; 14: 674-686.
20. Graham RK et al. Cell 2006; 125: 1179-1191.